Most people who have taken psychiatric medications can describe a familiar experience: you start a medication, wait several weeks, and hope it helps. Sometimes it works. Sometimes it only partially helps. Sometimes the side effects become a bigger problem than the symptoms you were trying to treat.
For some individuals, this process repeats multiple times. Different medications, dosage adjustments, and medication switches can feel frustrating and unpredictable. It often raises an important question:
Is there a more informed way to choose psychiatric medications?
Pharmacogenetic testing can help answer that question.
What Is Pharmacogenetic Testing?
Pharmacogenetic testing examines specific genes that influence how your body processes certain medications. Rather than testing all of your genes, the test focuses on genetic variations that affect medication metabolism and response.
Many psychiatric medications are processed by liver enzymes known as the cytochrome P450 (CYP450) system, particularly enzymes such as CYP2D6 and CYP2C19. These enzymes help break down many antidepressants, antipsychotics, and some ADHD medications.
Based on your genetic profile, you may be classified as:
- Poor metabolizer
- Intermediate metabolizer
- Normal metabolizer
- Rapid or ultra-rapid metabolizer
These categories help providers understand how your body may process certain medications.
Why Medication Metabolism Matters
Medication metabolism can significantly influence both effectiveness and side effects.
If you are a poor metabolizer, your body may process a medication more slowly than expected. As a result, medication levels can become higher than intended, increasing the risk of side effects.
If you are an ultra-rapid metabolizer, your body may process a medication too quickly. In that case, medication levels may never remain high enough to provide the intended therapeutic benefit.
Without pharmacogenetic testing, these differences are often invisible and may be mistaken for medication failure or intolerance.
What Pharmacogenetic Testing Can and Cannot Tell You
One common misconception is that pharmacogenetic testing can identify the “best” psychiatric medication for a person.
It cannot.
Pharmacogenetic testing is not a diagnostic tool, and it cannot determine whether someone has depression, bipolar disorder, anxiety, ADHD, or another mental health condition.
What it can do is provide information about how your body is likely to process certain medications.
The test may help identify:
- Medications likely to be metabolized normally
- Medications that may carry a higher risk of side effects
- Medications that may require dose adjustments
- Medications that may be less effective because of rapid metabolism
This information gives providers another piece of evidence when making treatment decisions.
Who May Benefit Most?
Pharmacogenetic testing can be particularly helpful for individuals who:
- Have tried multiple psychiatric medications without success
- Experienced significant side effects from medications
- Had medications that seemed ineffective despite adequate dosing
- Take multiple medications where drug interactions may be a concern
- Want additional information to guide medication selection
While it may also be useful for individuals beginning treatment, the greatest benefit is often seen in those with a history of difficult medication responses.
Understanding the Limitations
Pharmacogenetic testing is a valuable tool, but it is not a complete solution.
Medication response depends on many factors, including:
- Psychiatric diagnosis
- Symptom severity
- Medical conditions
- Other medications
- Sleep quality
- Stress levels
- Trauma history
- Lifestyle factors
Even if a medication is genetically compatible, it may still not be the right choice for a particular individual.
The test provides useful information, but it should always be interpreted within the context of a comprehensive psychiatric evaluation.
Pharmacogenetic Testing at Access Psychiatry
At Access Psychiatry, Dr. Mapendo Karen Safari uses an evidence-based, personalized approach to psychiatric medication management.
When clinically appropriate, pharmacogenetic testing may be incorporated into treatment planning to help guide medication selection and dosing decisions. The goal is not to replace clinical judgment, but to provide additional information that may reduce uncertainty and improve treatment outcomes.
If you have struggled with medication side effects, experienced limited benefit from previous treatments, or would like a more individualized approach to psychiatric care, pharmacogenetic testing may be worth discussing during your appointment.
Access Psychiatry
Glen Burnie Office
7310 Ritchie Highway, Suite 200
Glen Burnie, MD 21061
(443) 302-9788
Laurel Office
14504 Greenview Drive, Suite 301
Laurel, MD 20707
(301) 709-5921
Schedule an appointment at www.accesstopsychiatry.com
Mental health begins with access.